Abstract
The pandemic of diabetes and its related complications continues unabated despite strides in understanding its pathophysiology and the availability of new therapeutic interventions. Approximately 80% of people with diabetes live in poor and developing countries, and many of them, especially those living in rural areas and small towns, are without access to adequate basic health care. Further as discussed in Chap. 6, the lack of access to adequate nutrition and the reduced opportunities for exercise in developing countries have created an obesity epidemic, which parallels the rising prevalence of diabetes and gestational diabetes (GDM). Unfortunately, there are scarce data regarding the short- and long-term health and socioeconomic consequences of gestational diabetes in these countries. On the basis of the experience of a diabetes health care provider in India, it is found that individuals and health care systems are unable to cope with the tremendous economic burden of this disease. It is essential that the health care planners in developing countries (1) make screening, diagnosis, and treatment of GDM and the preconception, antepartum, and postpartum care of women with type 2 diabetes (DM2) “available,” “accessible,” and, most importantly, “affordable” to their citizens. The aim of this chapter is to present what is known about the rising prevalence of diabetes and GDM in the developing countries of the “third world” and discuss the complex issues related to access to health care.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Available at http://unpan1.un.org/intradoc/groups/public/documents/un/unpan008092.pdf Last accessed 12th August 2008
Diabetes Atlas, third edition © International Diabetes Federation, 2006
King H, Aubert R, Herman W. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 1998;21:1414–1431
Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047–1053
Berkowitz G, Lapinski R, Wein R, et al. Race/ethnicity and other risk factors for gestational diabetes. Am J Epidemiol 1992;135:965–973
Coustan D. Gestational diabetes. In: Diabetes in America, 2nd edn. Harris MI (ed.) Bethesda, MD: National Institutes of Health, 1995, pp. 703–716
King H. Epidemiology of glucose intolerance and gestational diabetes in women of childbearing age. Diabetes Care 1998;21(Suppl. 2):B9–B13
Ferrara A. Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care 2007;30(Suppl. 2):S141–S146
King H. Epidemiology of glucose intolerance and gestational diabetes in women of childbearing age. Diabetes Care 1998;21:B9–B13
WHO Ad Hoc Diabetes Reporting Group. Diabetes and impaired glucose tolerance in women aged 20–39 years. World Health Stat Q 1992;45:321–327
Green J, Pawson I, Schumacher L, et al. Glucose tolerance in pregnancy: ethnic variation and influence of body habitus. Am J Obstet Gynecol 1990;163:86–92
Ferrara A, Hedderson MM, Quesenberry CP, et al. Prevalence of gestational diabetes mellitus detected by the National Diabetes Data Group or the Carpenter and Coustan plasma glucose thresholds. Diabetes Care 2002;25:1625–1630
Dabelea D, Snell-Bergeon J, Hartsfield C, et al. Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program. Diabetes Care 2005;28:579–584
Engelgau M, Herman W, Smith P, et al. The epidemiology of diabetes and pregnancy in the US, 1988. Diabetes Care 1995;18:1029–1033
Bloomgarden Z. Diabetes and pregnancy. Diabetes Care 2000;23:1699–1702
Lucas M, Lowe T, Bowe L, et al. Class A1 gestational diabetes: a meaningful diagnosis? Obstet Gynecol 1993;82:250–265
Solomon C, Willett W, Carey V, et al. A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA 1997;278:1078–1083
Beischer N, Oats J, Henry O, et al. Incidence and severity of gestational diabetes mellitus according to country of birth in women living in Australia. Diabetes 1991;40(Suppl. 2):35–38
Ishak M, Petocz P. Gestational diabetes among Aboriginal Australians: prevalence, time trend, and comparisons with non-Aboriginal Australians. Ethn Dis 2003;13:55–60
Cheung N, Wasmer G, Al-Ali J. Risk factors for gestational diabetes among Asian women. Diabetes Care 2001;24:955–956
Dornhorst A, Paterson C, Nicholls J, et al. High prevalence of gestational diabetes in women from ethnic minority groups. Diabet Med 1992;9:820–825
Keshavarz M, Cheung N, Babaee G, et al. Gestational diabetes in Iran: incidence, risk factors and pregnancy outcomes. Diabetes Res Clin Pract 2005;69:279–286
Hadaegh F., Tohidi M., Harati H., et al. Prevalence of gestational diabetes mellitus in southern Iran (Bandar Abbas City). Endocr Pract 2005;11:313–318
Larijani B, Hossein-Nezhad A, Rizvi S, et al. Cost analysis of different screening strategies for gestational diabetes mellitus. Endocr Pract 2003;9:504–509
Schmidt M, Duncan B, Reichelt A, et al. Gestational diabetes mellitus diagnosed with a 2-h 75-g oral glucose tolerance test and adverse pregnancy outcomes. Diabetes Care 2001;24:1151–1155
Seyoum B, Kiros K, Haileselase T, et al. Prevalence of gestational diabetes mellitus in rural pregnant mothers in northern Ethiopia. Diabetes Res Clin Pract 1999;46:247–251
Zargar A, Sheikh M, Bashir M, et al. Prevalence of gestational diabetes mellitus in Kashmiri women from the Indian subcontinent. Diabetes Res Clin Pract 2004;66:139–145
Seshiah V, Balaji V, Balaji M, et al. Gestational diabetes mellitus in India. J Assoc Physicians India 2004;52:707–711
Hill J, Krishnaveni G, Annama L, et al. Glucose tolerance in pregnancy in South India: relationships to neonatal anthropometry. Acta Obstet Gynecol Scand 2005;84(2):159–65
Erem C, Cihanyurdu N, Deger O, et al. Screening for gestational diabetes mellitus in northeastern Turkey (Trabzon City). Eur J Epidemiol 2003;18:39–43
Yalcin H, Zorlu G. Threshold value of glucose screening tests in pregnancy: could it be standardized for every population? Am J Perinatol 1996;13:317–320
Yang X, Hsu-Hage B, Zhang H, et al. Gestational diabetes mellitus in women of single gravidity in Tianjin City, China. Diabetes Care 2002;25:847–851
Al Mahroos S, Nagalla D, Yousif W, et al. A population-based screening for gestational diabetes mellitus in non-diabetic women in Bahrain. Ann Saudi Med 2005;25:129–133
Santos-Ayarzagoitia M, Salinas-Martinez A, Villarreal-Perez J. Gestational diabetes: validity of ADA and WHO diagnostic criteria using NDDG as the reference test. Diabetes Res Clin Pract 2006;74(3):322–328
Hassan A. Screening of pregnant women for gestational diabetes mellitus. J Ayub Med Coll Abbottabad 2005;17:54–58
Khan K. Gestational diabetes in a developing country; experience of screening at the Aga Khan University Medical Centre, Karachi. J Pak Med Assoc 1991;41:31–33
Jawad F, Irshaduddin P. Prevalence of gestational diabetes and pregnancy outcome in Pakistan. East Mediterr Health J 1996;2:268–273
Wagaarachchi P, Fernando L, Premachadra P, et al. Screening based on risk factors for gestational diabetes in an Asian population. J Obstet Gynaecol 2001;21:32–34
Siribaddana S, Deshabandu R, Rajapakse D, et al. The prevalence of gestational diabetes in a Sri Lankan antenatal clinic. Ceylon Med J 1998;43(2):88–91
The HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358:1991–2002
International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome, Available at http://www.idf.org/webdata/docs/IDF_Metasyndrome_definition.pdf Last Accessed 16th August 2006
Buchanan T, Xiang A. Gestational diabetes mellitus. J Clin Invest 2005;115:485–491
Di Cianni G, Miccoli R, Volpe L, et al. Intermediate metabolism in normal pregnancy and in gestational diabetes. Diabetes Metab Res Rev 2003;19:259–270
Perkins J, Dunn J, Jagasia S. Perspectives in gestational diabetes mellitus: a review of screening, diagnosis, and treatment. Clin Diabetes 2007;25:57–62
Chu S, Callaghan W, Kim S, et al. Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care 2007;30(8):2070–2076
Barbour L, McCurdy C, Hernandez T, et al. Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care 2007;30(Suppl. 2):S112–S119
Buchanan T, Xiang A, Kjos S, et al. What is gestational diabetes? Diabetes Care 2007;30(Suppl. 2):S105–S111
Setji T, Brown A, Feinglos M. Gestational diabetes mellitus. Clin Diabetes 2005;23(1):17–24
Retnakaran R, Hanley A, Connelly P et al. Ethnicity modifies the effect of obesity on insulin resistance in pregnancy: a comparison of Asian, South Asian, and Caucasian women. J Clin Endocrinol Metab 2006;91(1):93–97
Xiong X, Saunders L, Wang F, et al. Gestational diabetes mellitus: prevalence, risk factors, maternal and infant outcomes. Int J Gynaecol Obstet 2001;75:221–228
Wolf M, Sauk J, Shah A, et al. Inflammation and glucose intolerance: a prospective study of gestational diabetes mellitus. Diabetes Care 2004;27:21–27
Ategbo J, Grissa O, Yessoufou A, et al. Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J Clin Endocrinol Metab 2006;91(10):4137–4143
Kahn S, Zinman B, Haffner S, et al. Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes. Diabetes 2006;55(8):2357–2364
Retnakaran R., Hanley A, Raif N, et al. C-reactive protein and gestational diabetes: the central role of maternal obesity. J Clin Endocrinol Metab 2003;88:3507–3512
Retnakaran R., Hanley A, Raif N, et al. Reduced adiponectin concentration in women with gestational diabetes: a potential factor in progression to type 2 diabetes. Diabetes Care 2004;27:799–800
Richardson AC, Carpenter MW. Inflammatory mediators in gestational diabetes mellitus. Obstet Gynecol Clin North Am 2007;34:213–224
Desoye G, Hauguel-de Mouzon S. The human placenta in gestational diabetes mellitus. The insulin and cytokine network. Diabetes Care 2007;30:S120–S126
Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM. Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest 1995;96:88–98
Raji A, Seely EW, Arky RA, Simonson DC. Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab 2001;86:5366–5371
Joshi R. Metabolic syndrome – emerging clusters of the Indian phenotype. J Assoc Physicians India 2003;51:445–446
Nahum G, Huffaker B. Racial differences in oral glucose screening test results: establishing race-specific criteria for abnormality in pregnancy. Obstet Gynecol 1993;81:517–522
Esakoff T, Cheng Y, Caughey A. Screening for gestational diabetes: different cut-offs for different ethnicities? Am J Obstet Gynecol 2005;193:1040–1044
ADA. Position statement: gestational diabetes mellitus. Diabetes Care 2004;27:S88–S90
Metzger B, Coustan D. Organizing Committee: summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 1998;21(Suppl. 2):B161–B167
de Sereday M, Damiano M, Gonzalez C, et al. Diagnostic criteria for gestational diabetes in relation to pregnancy outcome. J Diabetes Complications 2003;17(3):115–119
Vitoratos N, Salamalekis E, Bettas P, et al. Which is the threshold glycose value for further investigation in pregnancy? Clin Exp Obstet Gynecol 1997;24(3):171–173
Senanayake H, Seneviratne S, Ariyaratne H, et al. Screening for gestational diabetes mellitus in southern Asian women. J Obstet Gynaecol Res 2006;32(3):286–291
Brody S, Harris R, Lohr K. Screening for gestational diabetes: a summary of the evidence for the U.S. Preventive Services Task Force. Obstet Gynecol 2003;101:380–392
Sadikot S, Nigam A, Das S, et al. The burden of diabetes and impaired glucose tolerance in India using the WHO 1999 criteria: prevalence of diabetes in India study (PODIS). Diabetes Res Clin Pract 2004;66(3):301–307
Sadikot S, Nigam A, Das S, et al. The burden of diabetes and impaired fasting glucose in India using the ADA 1997 criteria: prevalence of diabetes in India study (PODIS). Diabetes Res Clin Pract 2004;66(3):293–300
Available at http://www.rediff.com/money/2006/aug/10capita.htm Last accessed 12th March 2008
Available at http://www.indiatogether.org/2006/mar/ddz-povline.htm Last accessed 12th March 2008
Human Development Report 2006, United Nations. http://hdr.undp.org/hdr2006
Available at http://www.thehindubusinessline.com/2004/04/09/stories/2004040900090900.htmLast accessed 12th August 2008
Available at http://timesofindia.indiatimes.com/articleshow/1850075.cms Last accessed 12th August 2008
Kale S, Kulkarni S, Lubree H, et al. Characteristics of gestational diabetic mothers and their babies in an Indian diabetes clinic. J Assoc Physicians India 2005;53:857–63
Kjos A, Buchanan T. Gestational diabetes mellitus. N Engl J Med 1999;341:1749–1756
Löbner K, Knopff A, Baumgarten A, et al. Predictors of postpartum diabetes in women with gestational diabetes mellitus. Diabetes 2006;55:792–797
Coustan D, Carpenter M, O’Sullivan P, et al. Gestational diabetes mellitus: predictors of subsequent disordered glucose metabolism. Am J Obstet Gynecol 1993;168:1139–1145
Kim C, Newton K, Knopp R. Gestational diabetes and the incidence of type 2 diabetes. Diabetes Care 2002;25:1862–1868
Catalano P, Kirwan J, Haugel-de Mouzon S, et al. Gestational diabetes and insulin resistance: role in short- and long-term implications for mother and fetus. J Nutr 2003;133:1674S–1683S
Peters R, Kjos S, Xiang A, et al. Long-term diabetogenic effect of single pregnancy in women with previous gestational diabetes mellitus. Lancet 1996;347:227–230
Carr D, Gabbe S. Gestational diabetes: detection, management, and implications. Clin Diabetes 1998;16(1):4–13
Buchanan T, Xiang A, Kjos S, et al. Antepartum predictors of the development of type 2 diabetes in Latino women 11–26 months after pregnancies complicated by gestational diabetes. Diabetes 1999;48:2430–2436
Buchanan T, Xiang A, Peters R, et al. Preservation of pancreatic beta cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 2002;51:2796–2803
Tuomilehto J, Lindstrom J, Eriksson J, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343–1350
Knowler W, Barrett-Conner E, Fowler S, et al. Diabetes Prevention Program Research Group.: Reduction in the incidence of type 2 diabetes with life style intervention or metformin. N Engl J Med 2002;346:393–403
Pan X, Li G, Hu Y, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. Diabetes Care 1997;20:537–544
Ramachandran A, Snehalatha C, Mary S, et al. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 2006;49:289–297
Chiasson J, Josse R, Gomis R, et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 2002;359:2072–2077
DREAM Trial Investigators. DREAM: Effect of ramapril on the incidence of diabetes. N Engl J Med 2006;355:1551–1562
DREAM Trial Investigators. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: randomised controlled trial. Lancet 2006;368:1096–1105
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Sadikot, S.M. (2009). The Epidemiology of Diabetes in Women and the Looming Epidemic of GDM in the Third World. In: Tsatsoulis, A., Wyckoff, J., Brown, F. (eds) Diabetes in Women. Contemporary Diabetes. Humana Press. https://doi.org/10.1007/978-1-60327-250-6_12
Download citation
DOI: https://doi.org/10.1007/978-1-60327-250-6_12
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60327-249-0
Online ISBN: 978-1-60327-250-6
eBook Packages: MedicineMedicine (R0)